WTA adopts mandatory SRY gene test for all tour players

The Women's Tennis Association has instituted a mandatory, one-time genetic test for all players on its tour, marking the most significant update to its eligibility policy in decades. The new rule, which took effect this month, requires every athlete to undergo screening for the SRY gene, a marker found on the Y chromosome, to confirm eligibility to compete in women's professional tennis. Players who refuse the test or are found ineligible face potential bans, loss of ranking points and prize money, and public disclosure.

The WTA announced the policy change following a comprehensive review that included consultation with its members and an examination of evolving standards across women's sport. In a statement, the organization said its Women's Eligibility Policy is designed to promote equal athletic opportunities and maintain fair competition. The policy, first introduced in 1975, has been updated to establish a clear, uniform standard based on biological sex, moving away from the previous case-by-case review system used for suspected cases.

Eligibility will be confirmed through a one-time SRY gene screen, with the WTA pledging to implement the process with privacy safeguards...